- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03516058
Impact Assessment of Simulation-Based Education on Anesthesiology Trainee in Ultrasound-Guided Transversus Abdominis Plane Block Using an Anesthetized Porcine Model
The purpose of this study was to investigate the effect of simulation based practice on anesthesiology trainee in ultrasound-guided transversus abdominis plane(TAP) block using an anesthetized porcine model.
The residents filled out a questionnaire before and after the training session. The questionnaires consisted of knowledge including ultrasound anatomy and block technique, comfort, confidence, and axiety levels for the TAP block.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Department of Anesthesiology and Pain Medicine , Anesthesia and Pain Research Institute, Yonsei University College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants included second-year residents, third-year residents who can participate in the anesthesiology simulation training.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
impact of a simulation-based ultrasound-guided TAP block training session_Comfort level
Time Frame: within 1 week after training session
|
5-point Likert scale (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high
|
within 1 week after training session
|
|
impact of a simulation-based ultrasound-guided TAP block training session_Comfort level
Time Frame: within 2 months after training session
|
5-point Likert scale (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high
|
within 2 months after training session
|
|
impact of a simulation-based ultrasound-guided TAP block training session_Overall confidence level
Time Frame: within 1 week after training session
|
5-point Likert scale (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high
|
within 1 week after training session
|
|
impact of a simulation-based ultrasound-guided TAP block training session_Overall confidence level
Time Frame: within 2 months after training session
|
5-point Likert scale (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high
|
within 2 months after training session
|
|
impact of a simulation-based ultrasound-guided TAP block training session_Overall anxiety level
Time Frame: within 1 week after training session
|
5-point Likert scale (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high
|
within 1 week after training session
|
|
impact of a simulation-based ultrasound-guided TAP block training session_Overall anxiety level
Time Frame: within 2 months after training session
|
5-point Likert scale (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high
|
within 2 months after training session
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 4-2018-0208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.